Who
Shaheen Wirk
Director
Company insider
Files Form 4 as: Director, Corvex; Director, Tvardi Therapeutics.
In numbers
- Trades disclosed
- 22
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 2 Jan 2025
- Last trade
- 13 Mar 2026
- Last filed
- 17 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Mar 2026filed 17 Mar 2026 | MOVE CorvexPayments & Processors | SEC FORM 4 Code M | $13K10,000 at $1.25 | filing |
| 13 Mar 2026filed 17 Mar 2026 | MOVE Corvexoption or derivative · Payments & Processors | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | MOVE Corvexoption or derivative · Payments & Processors | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | MOVE CorvexPayments & Processors | SEC FORM 4 Code M | $13K10,000 at $1.25 | filing |
| 9 Jan 2026filed 12 Jan 2026 | MOVE CorvexPayments & Processors | SEC FORM 4 Code A | —2,980 at $0.00 | filing |
| 9 Jan 2026filed 12 Jan 2026 | MOVE CorvexPayments & Processors | SEC FORM 4 Code A | —2,980 at $0.00 | filing |
| 9 Jan 2026filed 12 Jan 2026 | MOVE CorvexPayments & Processors | SEC FORM 4 Code A | —2,980 at $0.00 | filing |
| 9 Jan 2026filed 12 Jan 2026 | MOVE CorvexPayments & Processors | SEC FORM 4 Code A | —2,980 at $0.00 | filing |
| 3 Nov 2025filed 10 Nov 2025 | MOVE Corvexoption or derivative · Payments & Processors | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 3 Nov 2025filed 10 Nov 2025 | MOVE CorvexPayments & Processors | SEC FORM 4 Code D | —6,841 at $0.00 | filing |
| 3 Oct 2025filed 7 Oct 2025 | MOVE CorvexPayments & Processors | SEC FORM 4 Code A | —20,685 at $0.00 | filing |
| 3 Jul 2025filed 3 Jul 2025 | MOVE CorvexPayments & Processors | SEC FORM 4 Code A | —18,657 at $0.00 | filing |
| 9 May 2025filed 13 May 2025 | MOVE CorvexPayments & Processors | SEC FORM 4 Code A | —29,070 at $0.00 | filing |
| 17 Apr 2025filed 21 Apr 2025 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 15 Apr 2025filed 2 May 2025 | TVRD Tvardi TherapeuticsBiotechnology | SEC FORM 4 Code A | —176,030 | filing |
| 15 Apr 2025filed 2 May 2025 | TVRD Tvardi TherapeuticsBiotechnology | SEC FORM 4 Code A | —263,164 | filing |
| 15 Apr 2025filed 17 Apr 2025 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,011 | filing |
| 15 Apr 2025filed 17 Apr 2025 | TVRD Tvardi TherapeuticsBiotechnology | SEC FORM 4 Code A | —4,191 | filing |
| 15 Apr 2025filed 17 Apr 2025 | TVRD Tvardi TherapeuticsBiotechnology | SEC FORM 4 Code J | —176,030 | filing |
| 15 Apr 2025filed 17 Apr 2025 | TVRD Tvardi TherapeuticsBiotechnology | SEC FORM 4 Code J | —263,164 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.